Long 20mono
Mini logo

Monoclonals Inc.

Developing novel monoclonal antibodies for rapid tests which diagnose diseases, specifically for resource poor areas.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Ellsworth, ME, US
  • Currency USD
  • Founded April 2016
  • Employees 2
  • Incorporation Type C-corp
  • Website monoclonalsin.com

Company Summary

Monoclonals Inc., founded in April of 2016, is a newly established antibody producing company with a focus on developing novel antibody products. We are currently registered with National Institute of Health (NIH) for the purpose of obtaining a grant which will help develop novel rapid test kits for diagnostic purposes. The company is privately funded and at product development phase.